• Explore /
  • Poster
  • / <span>Transcriptomic signatures of MSI-high metastatic colorectal cancer to predict efficacy of immune checkpoint inhibitors.</span>

Transcriptomic signatures of MSI-high metastatic colorectal cancer to predict efficacy of immune checkpoint inhibitors.

Abstract Poster

Authors

null

Claire Gallois

Institut du Cancer Paris CARPEM, APHP, Digestive Oncology Department, APHP.Centre - Université Paris Cité, Hôpital Européeen G. Pompidou, Paris, France

Claire Gallois , Matteo Landi , Julien Taieb , Sara Lonardi , Francesca Bergamo , Rossana Intini , Giulia Maddalena , Filippo Pietrantonio , Francesca Corti , Margherita Ambrosini , Antonia Martinetti , Marco Maria Germani , Chiara Boccaccio , Guglielmo Vetere , Sophie Mouillet-Richard , Aurélien de Reynies , Pierre Laurent Puig , Chiara Cremolini

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 3570)

DOI

10.1200/JCO.2023.41.16_suppl.3570

Abstract #

3570

Poster Bd #

270

Abstract Disclosures

Similar Posters

First Author: Eugenia Li Ling Yeo

First Author: Yu Fujiwara

First Author: Sun Young Kim

First Author: Federica Marmorino